SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 11.0% Passive Stake in Glaukos Corp
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a passive beneficial ownership of 11.0% in Glaukos Corp's common stock as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 6,078,556.30 shares of Glaukos Corp's common stock.
- This ownership represents 11.0% of the total outstanding common stock of Glaukos Corp.
- FMR LLC holds sole voting power over 6,068,916.32 shares and sole dispositive power over 6,078,556.30 shares.
- Abigail P. Johnson holds sole dispositive power over 6,078,556.30 shares, with no sole or shared voting power.
- The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Glaukos Corp.
- FMR LLC is classified as a parent holding company, and Abigail P. Johnson is an individual reporting person.
- Several FMR LLC subsidiaries, including Fidelity Management & Research Company LLC, are identified as entities beneficially owning shares, with Fidelity Management & Research Company LLC owning 5% or greater of the outstanding shares.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive due to the disclosure of a significant, passive institutional stake by a reputable firm, which can be viewed as a vote of confidence in the company. However, as a routine ownership filing, it does not contain operational or financial news that would significantly alter sentiment.
Positives
- The disclosure of a significant 11.0% stake by a major institutional investor like FMR LLC can signal confidence in Glaukos Corp's long-term prospects.
- Increased institutional ownership may enhance the company's visibility and liquidity in the market.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding Glaukos Corp's future performance or strategic direction, as it is a beneficial ownership report.
Management Comments
- FMR LLC and Abigail P. Johnson certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Glaukos Corp.
Industry Context
This filing reflects a significant passive investment by a major asset manager in Glaukos Corp, a company operating in the medical technology sector, specifically ophthalmology. Such institutional holdings are common across publicly traded companies, indicating ongoing investor interest in the sector.
Stakeholder Impact
- Shareholders: May view the significant institutional ownership as a positive signal of investor confidence and stability.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC and its direct and indirect subsidiaries. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's Power of Attorney was incorporated by reference. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end). |
| 2025-02-11 | Date of joint filing agreement and signature date for the Schedule 13G Amendment No. 2. |
Keywords
Glaukos Corp, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.